Sigilon Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Sigilon Therapeutics's balance sheet done over the years? Its assets were worth $87,278,000 last year, which is less than in the previous period. 55% of Sigilon Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $48,136,000, which means an decrease by -28% compared compared to last year.

Debt to Assets

Sigilon Therapeutics, Inc. (NASDAQ:SGTX): Debt to assets
2018 67665000 103.76M 153.35%
2019 90378000 168.14M 186.04%
2020 225050000 78.89M 35.06%
2021 144369000 67.20M 46.55%
2022 87278000 48.13M 55.15%

SGTX Balance Sheet (2018 – 2022)

2022 2021 2020 2019 2018
Assets
Current assets:
Cash and cash equivalents
42.06M107.14M202.22M76.06M64.1M
Short term investments
27.56M16.21M000
Net receivables
3.45M59K177K136K0
Inventory
250K250K75K00
Other current assets
1.07M2.72M1.72M732K422K
Total current assets
74.41M126.39M204.21M76.93M64.53M
Non-current assets:
Property, Plant and Equipment
11.83M16.85M19.72M12.8M2.55M
Goodwill
00000
Intangible assets
00000
Long term investments
00000
Other non-current assets
1.03M1.11M1.11M641K576K
Total non-current assets
12.86M17.97M20.84M13.44M3.13M
Total assets
87.27M144.36M225.05M90.37M67.66M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
12.88M17.03M31.77M29.14M24.74M
Short term debt
11.15M6.51M5.36M3.37M667K
Total current liabilities
30.99M34.88M47.01M40.37M29.20M
Non-current liabilities:
Long term debt
16.90M26.98M31.7M21.67M4.28M
Deferred tax
00000
Other non-current liabilities
233K0176K90.53M59K
Total non-current liabilities
17.14M32.32M31.87M127.76M74.55M
Total liabilities
48.13M67.20M78.89M168.14M103.76M
Data sourceData sourceData source